| Expression pattern: |
DN |
| Associated gene: |
Ago2 |
| Associated microRNA: |
miR-93-5p |
| Biological function: |
circRNF13 represses migration, invasion and metastasis of lung adenocarcinoma cells; knockdown promotes migration and invasion, while overexpression inhibits migration and invasion. |
| Molecular mechanism: |
circRNF13 acts as a cytoplasmic ceRNA/miRNA sponge for miR-93-5p through association with Ago2, suggesting post-transcriptional regulation. |
| Biological pathway or process: |
migration (inhibits); invasion (inhibits); metastasis (inhibits); ceRNA regulation (other) |
| Detected method: |
Q
H
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Transfection; Transwell Assay; Wound Healing Assay; Bioinformatics Analysis |
| Clinical significance: |
circRNF13 expression is significantly negatively correlated with TNM staging and lymph node metastasis, and circRNF13 represents a potential novel biomarker and therapeutic target of lung adenocarcinoma. |
| Description: |
circRNF13 (hsa_circ_0001346), derived from RNF13, is down-regulated in lung adenocarcinoma tissues and is associated with TNM stage and lymph node metastasis. It mainly localizes in the cytoplasm and suppresses LAC cell migration, invasion and metastasis, at least partly by acting as an Ago2-associated sponge for miR-93-5p. The study proposes circRNF13 as a potential biomarker and therapeutic target for lung adenocarcinoma. |
| Confidence score: |
0.7974 |